Quarterly report · Q2
4323.TEDINET S100PJPL
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥21.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.0bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥992m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.0bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥738m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥687m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥748m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥692m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥15.7bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥15.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥6.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥9.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.6bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.0bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.0bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.3bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥819m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥839m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥86m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥81m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥57m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥273m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥487m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥593m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥60.16 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.91 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.32 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.22 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.16 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.6% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥89m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥89m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥852m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥19m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥184m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥719m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥719m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥71m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥28m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥556m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥11.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥89m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.9bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥33m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥33m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥764m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥906m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥897m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥8m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥203,000 |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥740m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥740m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥131m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥786m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥10.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥10.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥33m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 547
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember | 786028000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 130802000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember | 203000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1756224000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -763753000 | JPY |
| Operating income | Prior1YTDDuration | 992471000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember | 6870153000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember | 2051526000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 718883000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember | 1363476000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 11004040000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 11004040000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember | 42063000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember | 28015000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember | 18821000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 88900000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -88900000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember | 6912216000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember | 2079542000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 718883000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember | 1382298000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 11092940000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -88900000 | JPY |
| Net sales | CurrentYTDDuration | 11004040000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember | 1044698000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember | 555731000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 70923000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember | 184168000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 1855521000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -851927000 | JPY |
| Operating income | CurrentYTDDuration | 1003593000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-11-11 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第51期第２四半期(自 2022年７月１日 至 2022年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)日本システム技術株式会社 | |
| Company name in english cover page | FilingDateInstant | Japan System Techniques Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 平林 武昭 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪市北区中之島二丁目３番18号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０６(４５６０)１０００(代) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)常務取締役執行役員 大門 紀章 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪市北区中之島二丁目３番18号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)０６(４５６０)１０００(代) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)常務取締役執行役員 大門 紀章 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05236 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |